AstraZeneca advances weight-loss pill to take aim at obesity leaders ○
found
a story from Financial Times ✅ › Financial Times
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
AstraZeneca
since
auto-detected in 67 stories
21 hours ago
Pill from drugmaker would put it into competition with market leaders Novo Nordisk and Eli Lilly
4 days ago
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success ⊕⊕
AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout the research process.
39 days ago
AstraZeneca stock falls after FDA panel votes against new cancer drug ⊖
The advisory panel wasn't convinced that a clinical trial proved that early switching to camizestrant improved long-term survival rates.
41 days ago
UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies ⊕⊕
AstraZeneca and GSK, the U.K.'s second and ninth most valuable companies, both saw first-quarter profits beat expectations early Wednesday.
74 days ago
AstraZeneca stock jumps 4% after surprise trial win for lung disease drug where rivals have failed ⊕
The experimental drug reduced flare-ups for patients with chronic obstructive pulmonary disease, Astra said Friday.
3 months ago
AstraZeneca CEO hails NHS drug price deal but keeps pause on £200m UK investment ⊕
found
a story from The Guardian ⚠️ › International
Pascal Soriot suggests UK-US agreement will not be enough to revive plan to expand Cambridge site
Business live – latest updates
The boss of Britain’s biggest pharmaceutical company has said the govern…
4 months ago
AstraZeneca is listing in New York, as Big Pharma balances the huge U.S. market with China's tempting innovation ⊕
AstraZeneca announces multibillion dollar investments in China as Big Pharma is increasingly looking east for innovation.
AstraZeneca strikes £13bn fat jabs deal with Chinese drug giant ⊖
found
a story from The Daily Mail 💩 › The Daily Mail
Under the deal, the FTSE 100 group will have the exclusive global rights, outside China, to CSPC's once-a-month jab that is about to start early-stage clinical trials.
AstraZeneca strikes $4.7bn China deal to boost weight-loss drugs pipeline ○
Drugmaker expands push into fast-growing market
Airbus, AstraZeneca and HSBC executives join UK's Starmer on high-stakes China trip ○
found
Executives from Airbus, AstraZeneca and HSBC are joining Prime Minister Keir Starmer on a rare China visit, highlighting the business focus of the trip amid strained global trade relations.